Clovis Oncology, Inc.
Country
USA
Краткое название
Clovis Oncology, Inc.
Headquarters
2525 28th Street Suite 100
Members of the board
Patrick J. Mahaffy — President & Chief Executive Officer; Director
Erle T. Mast — Executive Vice President & Chief Financial Officer
Andrew R. Allen, BM, BCh, MA, MRCP, PhD — Executive Vice President of Clinical & Pre-Clinical Development & Chief Medical Officer
Steven L. Hoerter — Senior Vice President, Commercial
Gillian C. Ivers-Read — Executive Vice President, Technical Operations & Chief Regulatory Officer
Erle T. Mast — Executive Vice President & Chief Financial Officer
Andrew R. Allen, BM, BCh, MA, MRCP, PhD — Executive Vice President of Clinical & Pre-Clinical Development & Chief Medical Officer
Steven L. Hoerter — Senior Vice President, Commercial
Gillian C. Ivers-Read — Executive Vice President, Technical Operations & Chief Regulatory Officer
Categories medicine
Oncology
Stage of the project
Production
Disease
Lung cancer
Ticker
CLVS
Current owners
Brian G. Atwood
M. James Barrett, PhD
James Blair, PhD
Paul Klingenstein
Patrick J. Mahaffy
Edward J. McKinley
John Reed, MD, PhD
Thorlef Spickschen
M. James Barrett, PhD
James Blair, PhD
Paul Klingenstein
Patrick J. Mahaffy
Edward J. McKinley
John Reed, MD, PhD
Thorlef Spickschen
Assets
2.9300
Technology
Devices, Technologies, Pharmaceuticals, Chemistry